---
title: "Gilead Sciences (GILD) Receives a Buy from Bernstein"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/298227334.md"
description: "Bernstein analyst Courtney Breen maintained a Buy rating on Gilead Sciences today and set a price target of $160.00. Breen covers the Healthcare sector, focusing on stocks such as Eli Lilly & Co, Merck & Company, and Moderna. According to TipRanks, Breen has an average return of 21.0% and an 89.09% success rate on recommended stocks. In a report released on August 31, Mizuho Securities also maintained a Buy rating on the stock with a $170.00 price target."
datetime: "2026-09-07T16:25:46.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/298227334.md)
  - [en](https://longbridge.com/en/news/298227334.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/298227334.md)
generator: "portal-rs"
---

# Gilead Sciences (GILD) Receives a Buy from Bernstein

Bernstein analyst Courtney Breen maintained a Buy rating on Gilead Sciences today and set a price target of $160.00.

Breen covers the Healthcare sector, focusing on stocks such as Eli Lilly & Co, Merck & Company, and Moderna. According to TipRanks, Breen has an average return of 21.0% and an 89.09% success rate on recommended stocks. 

In a report released on August 31, Mizuho Securities also maintained a Buy rating on the stock with a $170.00 price target.

### Related Stocks

- [GILD.US](https://longbridge.com/en/quote/GILD.US.md)
- [LLY.US](https://longbridge.com/en/quote/LLY.US.md)
- [MRK.US](https://longbridge.com/en/quote/MRK.US.md)
- [MRNA.US](https://longbridge.com/en/quote/MRNA.US.md)

## Related News & Research

- [HIV charities lament NICE snub for Gilead’s twice-yearly lenacapavir](https://longbridge.com/en/news/298763671.md)
- [Gilead Sciences Sees Sunlenca Launch Fueling Long-Term HIV Growth](https://longbridge.com/en/news/298621247.md)
- [How Cathie Wood's fund gave us a back door to Moderna's breakthrough](https://longbridge.com/en/news/298769510.md)
- [Citi Sticks to Its Buy Rating for Zenas BioPharma, Inc. (ZBIO)](https://longbridge.com/en/news/298700603.md)
- [Trump Is Still Very Much Operating Off ‘Concepts’ Of A Health Care Plan](https://longbridge.com/en/news/298872418.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**